Achalasia
79
12
14
31
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.4%
9 terminated out of 79 trials
77.5%
-9.0% vs benchmark
10%
8 trials in Phase 3/4
6%
2 of 31 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 31 completed trials
Clinical Trials (79)
Autonomic Dysfunction and Hemodynamic Instability During Per-oral Endoscopic Myotomy
Clinical Outcomes, Safety, and Effectiveness of Speedboat UltraSlim™ in Per-Oral Endoscopic Myotomy (POEM)
Peroral Endoscopic Myotomy for the Treatment of Achalasia
Mechanisms of Weight Loss in Patients Diagnosed With Achalasia
VZV in the Enteric Nervous System: Pathogenesis and Consequences
Botox or Botox With Esophageal Dilation in Patients With Achalasia
PRospective Registry of Esophageal Motility
Disposable Endoscope Platform in Third Space Endoscopic Procedures
POEM Trial: Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM)
Per-Oral Endoscopic Myotomy (POEM) for the Treatment of Achalasia, Database Repository
Safety and Efficacy of a Novel SpydrBlade Flexible Bipolar in POEM
Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders
Minimally Invasive Surgery of the Gastro-esophageal Junction
Outcome Analysis of POEM and Endoluminal Therapies
Comprehensive Esophageal Diagnostics Study
POEM- Peroral Endoscopic Myotomy for Esophageal Motility Disorders
The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor
Electrosurgical Modes for Endoscopic Submucosal Dissection in Peroral Endoscopic Esophageal Myotomy
ARAT for Reflux Disease After Peroral Endoscopic Myotomy in Patients With Achalasia
Per-Oral Endoscopic Myotomy for Esophageal Swallowing Disorders